Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery

British Journal of Surgery

Volumn 101, Issue 11, 2014, Pages 1383-1390

  Kasivisvanathan, R ^a   Abbassi Ghadi, N ^b   Kumar, S ^b   Mackenzie, H ^b   Thompson, K ^a   James, K ^a   Mallett, S V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; TICLOPIDINE;

AGED; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CHEMICALLY INDUCED; COMPARATIVE STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROCEDURES; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; THROMBOELASTOGRAPHY; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; REOPERATION; RISK FACTORS; THROMBELASTOGRAPHY; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84907951865     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9592     Document Type: Article

References (31)

1. Douglas IJ, Evans SJ, Hingorani A.D., Grosso AM, Timmis A, Hemingway H et al. Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs. BMJ 2012; 345: e4388.
2. Howard-Alpe GM, de Bono J, Hudsmith L, Orr W.P., Foex P., Sear JW. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007; 98: 560-574.
3. Eberli D, Chassot PG, Sulser T, Samama C.M., Mantz J., Delabay A et al. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183: 2128-2136.
4. Chernoguz A, Telem DA, Chu E, Ozao-Choy J, Tammaro Y., Divino CM. Cessation of clopidogrel before major abdominal procedures. Arch Surg 2011; 146: 334-339.
5. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008; 34: 127-131.
6. Firanescu CE, Martens EJ, Schönberger JP, Soliman Hamad MA, van Straten AH. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009; 36: 856-862.
7. Spahn DR, Howell SJ, Delabays A, Chassot PG. Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 2006; 96: 675-677.
8. McFadden EP, Stabile E, Regar E., Cheneau E, Ong AT, Kinnaird T et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
9. Harty JA, McKenna P, Moloney D., D'Souza L, Masterson E. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg (Hong Kong) 2007; 15: 270-272.
10. Ferreiro JL, Angiolillo DJ. Clopidogrel response variability: current status and future directions. Thromb Haemost 2009; 102: 7-14.
11. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E., Alfonso F, Macaya C, Bass TA et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 2007; 49: 1505-1516.
12. Frontroth JP. Light transmission aggregometry. Methods Mol Biol 2013; 992: 227-240.
13. Malinin A, Pokov A, Swaim L., Kotob M, Serebruany V. Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel. Methods Find Exp Clin Pharmacol 2006; 28: 315-322.
14. Ranucci M, Baryshnikova E, Soro G., Ballotta A, De Benedetti D, Conti D; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011; 91: 123-129.
15. Cattano D, Altamirano AV, Kaynak H.E., Seitan C., Paniccia R, Chen Z et al. Perioperative assessment of platelet function by thromboelastograph platelet mapping in cardiovascular patients undergoing non-cardiac surgery. J Thromb Thrombolysis 2012; 35: 25-30.
16. Agarwal S, Coakley M, Coakely M., Reddy K, Riddell A, Mallett S. Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology 2006; 105: 676-683.
17. US Food and Drug Administration. 510(k) Substantial Equivalence, Determination, Decision Summary and Device and Instrument Template for TEG-PMA. http://www.accessdata.fda.gov/cdrh-docs/reviews/K041502.pdf [accessed 1 February 2014].
18. Bliden KP, DiChiara J, Tantry U.S., Bassi AK, Chaganti SK, Gurbel PA. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007; 49: 657-666.
19. Craft RM, Chavez JJ, Bresee S.J., Wortham DC, Cohen E, Carroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143: 301-309.
20. National Institute of Clinical Excellence. Preoperative Tests: the Use of Routine Preoperative Tests for Elective Surgery. Clinical Guideline 3; 2003. http://www.nice.org.uk/nicemedia/live/10920/29090/29090.pdf [accessed 1 February 2014].
21. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al. The Clavien-Dindo classification of surgical complications: five-years experience. Ann Surg 2009; 250: 187-196.
22. Prytherch DR, Whiteley MS, Higgins B, Weaver P.C., Prout WG, Powell SJ. POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity. Br J Surg 1998; 85: 1217-1220.
23. Gurbel PA, Bliden KP, Hiatt B.L., O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-2913.
24. Gurbel PA, Bliden KP, Hayes K.M., Yoho JA, Herzog WR, Tantry US. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005; 45: 1392-1396.
25. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 2005; 45: 1157-1164.
26. British National Formulary. British Medical Journal Publishing Group/Royal Pharmaceutical Society Publishing: London, 2007.
27. Albaladejo P, Marret E, Piriou V., Samama CM; French Society of Anesthesiology and Intensive Care. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force. Br J Anaesth 2006; 97: 580-582.
28. Grines CL, Bonow RO, Casey D.E., Gardner TJ, Lockhart PB, Moliterno DJ et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 117: 813-818.
29. Mahla E, Suarez TA, Bliden K.P., Rehak P., Metzler H, Sequeira AJ et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5: 261-269.
30. Kwak YL, Kim JC, Choi Y.S., Yoo KJ, Song Y, Shim JK. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 2010; 56: 1994-2002.
31. Ferraris VA, Saha SP, Oestreich J.H., Song HK, Rosengart T, Reece TB et al.; Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012; 94: 1761-1781.